Bringing Aberrant Proteins Back into the Fold
RARECast - A podcast by RARECast - Giovedì
Categorie:
Eric Richman, CEO of Gain Therapeutics, discusses its platform technology, how it works, and why it offers a compelling alternative to other approaches to treating lysosomal storage disorders.
